Nofima-SINTEF-UiT project develops fish feed from microalgae, cultivated using carbon dioxide emissions directly obtained from Finnfjord ferrosilicon manufacturing plant.
Pharmaceutical ingredients expert Jerome Quiohilag joins the Scottish biotech startup as Associate Director, as the company prepares to scale its operations with a new production facility this year.
With an estimated investment of EUR 30 million for Phase 1, the biotech company Microalgas Future will dedicate 50,000 square meters to the cultivation of microalgae.
Faster growth and increased omega-3 can be achieved through targeted breeding of microalgae, making it a promising ingredient for aquaculture feed, according to new research by Nofima.
